Getting Mounjaro (GLP-1) in Japan as a Foreign Resident: 2026 Complete Guide

Who this guide is for

You’re a foreign resident in Japan (long-term visa, spouse visa, permanent resident, working visa, or student) who is considering GLP-1 weight-loss medication. Maybe you’ve heard about Ozempic or Mounjaro from home. Maybe you’ve seen ads on Facebook from Juniper Japan. Maybe your Japanese doctor mentioned it’s available but couldn’t prescribe it under insurance.

This guide walks through what your options actually look like — with honest cost comparisons and the trade-offs. It is written by a Japanese clinic that serves foreign residents, so we have skin in the game, but we’ve tried to describe the landscape as it actually is, including our competitors.

The GLP-1 landscape in Japan (2026)

As of mid-2026, three main GLP-1 receptor agonists are relevant for weight management in Japan:

• Mounjaro (tirzepatide) — GIP/GLP-1 dual agonist by Eli Lilly. Approved in Japan for type 2 diabetes. Highest efficacy in trials (~20% weight loss at 15mg). Most commonly prescribed off-label for weight management.
• Wegovy (semaglutide) — GLP-1 by Novo Nordisk. This is the only GLP-1 with an approved obesity indication in Japan (since Nov 2023), but NHI-covered access is heavily restricted (BMI ≥35 or ≥27 with specific comorbidities plus additional criteria).
• Ozempic (semaglutide) — Same molecule as Wegovy, different branding. Approved for T2DM only. Prescribed off-label for weight loss.

Rybelsus (oral semaglutide) is also available but less commonly used for weight loss due to dosing constraints. Zepbound (Eli Lilly’s tirzepatide brand for obesity in the US) has been approved by Japan’s PMDA under the same active ingredient but is not yet widely stocked.

The insurance reality: 自由診療 (jiyu shinryo)

Here’s the single most important thing to understand as a foreign resident:

The Japanese term for this is 自由診療 (jiyu shinryo) — "free medical care," meaning free from insurance restrictions but self-paid. All private clinics prescribing GLP-1 for weight loss in Japan operate under this framework. It’s completely legal and standard; it just means insurance doesn’t chip in.

Even Wegovy, which has an approved obesity indication, faces strict NHI access criteria (BMI thresholds, prior diet-and-exercise attempts documented, specific comorbidities). In practice, most foreign residents seeking Wegovy for weight management also end up paying privately.

Four ways to access GLP-1 as a foreign resident

Language considerations

The good news: you do not need Japanese language ability to access GLP-1 care in Japan, provided you choose an English-friendly service.

Options 1 and 2 above are fully English-accessible. Option 3 requires Japanese fluency or a Japanese-speaking companion. Even Option 3 clinics are gradually adding English support as demand grows, but coverage is still spotty.

For online consultations at English-friendly clinics: English is the primary language for the visit itself, all prescriptions and receipts. For in-person visits, the physician speaks English but the reception staff may not — you’ll typically be routed to English-speaking staff on arrival.

Real-time translation on mobile phones (Google Translate camera, DeepL, etc.) works well enough for basic navigation of any Japanese clinic if you’re willing to try Option 3.

Honest cost comparison

Prices below are approximate and current as of mid-2026. Actual pricing varies by dose, package length, and clinic. All prices in JPY (¥1 USD ≈ ¥150).

Clinic type	2.5mg / mo (starter)	5mg / mo (maintenance)	Contract?
Nurse-led telehealth (e.g., Juniper JP)	~¥15,950	Not always separately priced	6-month typical
Physician-led English clinic (e.g., eHealth Clinic)	¥24,000	¥42,000	None (buy-once)
Domestic Japanese clinic (Nihonbashi, etc.)	¥6,000/pen (¥18,000-24,000/mo depending on titration)	~¥28,500 (¥9,500/pen)	Usually none
Bring from home country	Whatever you pay at home	Whatever you pay at home	N/A

Add typical shipping (¥1,000-2,000) if applicable. Contract-based clinics usually have escalating monthly costs; buy-once clinics have flat pricing per package with volume discounts (e.g., ¥42,000/month for 1mo becomes ¥33,600/month for 6mo at English-friendly clinics).

For long-term (12+ months), the total cost differences can add up significantly. A 6-month supply of 5mg Mounjaro at a physician-led English clinic is ~¥201,600 ($1,340 USD). Same amount at a domestic Japanese clinic might be ~¥171,000. Nurse-led telehealth may be lower on a monthly basis but often locks you into a contract structure.

Delivery and logistics across Japan

Yamato Transport’s refrigerated (cool) courier service handles almost all GLP-1 shipments in Japan. Coverage is nationwide including Hokkaido, Okinawa, and remote islands (with slightly longer transit times).

• Tokyo metro: Next-day delivery if ordered by cutoff
• Rest of Honshu, Shikoku, Kyushu: 1-2 days
• Hokkaido, Okinawa: 2-3 days
• Remote islands (Ogasawara, etc.): Case-by-case, may require special arrangement

If your address cannot accept refrigerated packages (some apartment lockers can’t, or if you’re not home during delivery windows), Yamato office pickup is available at their local offices. Use Yamato’s location finder to identify your nearest office.

Long-term supply considerations

GLP-1s work best as long-term therapy — most patients don’t reach or maintain their weight goals in a single 3-month course. As a foreign resident thinking about the multi-year picture, consider:

Reliability of supply

Japan hasn’t experienced the Mounjaro shortages that hit the US in 2023-2024. Supply from authorized distributors (Eli Lilly Japan, Novo Nordisk Japan) has been consistent. That said, this can change; verify supply status at consultation.

Contract vs no-contract

If you plan to be in Japan for a defined period (1-3 years on a working visa, for example), no-contract clinics let you stop when you leave without cancellation friction. Contract-based services (6-month plans) can be more cost-effective if you know you’ll stay the duration, but consider the exit friction.

Portability if you leave Japan

If you move back to your home country while on GLP-1, most clinics can prescribe a larger final supply (up to legal export limits) so you have continuity while you set up care in your new country. Coordinate this ~2 months before departure.

Dose changes over time

Standard Mounjaro titration is 2.5mg → 5mg → 7.5mg → 10mg (up to 15mg). Most patients stabilize at 5mg-10mg. Your clinic should reassess dose at each visit. Some cheaper telehealth services put you on autopilot at 5mg indefinitely; better clinics adjust based on your response.

When in-person vs online makes sense

For most stable, healthy adults on standard doses, online consultation is fine and convenient. For the following situations, we’d recommend the in-person option:

• Your first-ever consultation — meeting the physician face-to-face builds trust and enables more nuanced conversations about medical history
• You have complex medical history — thyroid disease family history, past pancreatitis, gallbladder issues, mental health considerations
• You’ve had trouble with GLP-1 side effects before — in-person assessment is more thorough
• You want an injection demonstration in person — some people learn better hands-on

Many foreign residents book the first consultation in person, then move to online-only for maintenance visits. Nothing prevents you from switching back to in-person any time.

Common pitfalls to avoid

1. Ultra-low-price traps

Services quoting ¥15,000/month sometimes bury the 6-month contract commitment in fine print, or the low starter price jumps significantly at higher doses. Read the total cost projection for your likely 6-12 month treatment before signing up.

2. Compounded “semaglutide” from grey-market sources

Some Japanese cosmetic clinics offer “compounded semaglutide” at very low prices. This is not brand-name Ozempic or Wegovy, and quality control is not guaranteed. Stick to Eli Lilly Mounjaro or Novo Nordisk Wegovy/Ozempic from clinics using authorized pharmaceutical distributors.

3. Assuming NHI will cover it later

Some patients assume that if they stay in Japan long enough, they’ll qualify for NHI coverage of weight-loss GLP-1. As of 2026, there’s no realistic pathway for weight-only coverage under NHI unless you develop type 2 diabetes. Budget for out-of-pocket cost for the duration of your treatment.

4. Ignoring lifestyle integration

Mounjaro reduces appetite dramatically but doesn’t fix underlying lifestyle habits. Long-term success requires nutrition and exercise adjustments alongside the medication. Clinics that only ship medication without any lifestyle guidance tend to have worse long-term outcomes for patients.

5. Stopping abruptly at end of prescription

Abrupt discontinuation of GLP-1s often causes rapid appetite return and weight regain. If you plan to stop, taper over 2-3 months with your physician’s guidance. See our Year 2 maintenance article for details.

FAQ